At the same time, development is in the works for a cheaper “off-the-shelf” version of its cell therapy that could be manufactured in different countries, potentially making the treatment more accessible to global markets.
The firm is also exploring the use of artificial intelligence to expand its therapies to other tumours and diseases such as lung and breast cancer.
Day6’s Young K will be holding his first solo concert in Singapore in January 2027. The South Korean singer-songwriter, vocalist and bassist will bring his…
SINGAPORE: Another 14 luxury condominium units and a Grade A office at Suntec Tower One forfeited in connection with Singapore’s largest money laundering case will…
Eligible titles can be identified by an official SG Culture Pass sticker on the cover. Local literary works were first included under the SG Culture Pass…
Tom’s Palette is known for its wide variety of sweet and savoury gelatos, and in the lead-up to the closure, the brand will bring back…
BILLION DOLLAR AI PUSH DBS is looking to technology – particularly AI and data-driven automation – to sustain earnings momentum and build long-term efficiency. The…